• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门诊药房消费者中药物治疗满意度问卷(TSQM 第二版)的层次结构效度

Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers.

作者信息

Atkinson Mark J, Kumar Ritesh, Cappelleri Joseph C, Hass Steven L

机构信息

Worldwide Outcomes Research, La Jolla Laboratories, Pfizer Inc, San Diego, CA 92121-1111, USA.

出版信息

Value Health. 2005 Nov-Dec;8 Suppl 1:S9-S24. doi: 10.1111/j.1524-4733.2005.00066.x.

DOI:10.1111/j.1524-4733.2005.00066.x
PMID:16336491
Abstract

OBJECTIVES

The objectives of this study were twofold: 1) to evaluate the construct validity of the Treatment Satisfaction Questionnaire for Medication (TSQM v. II) using structural equation modeling (SEM); and 2) to assess its concurrent validity using medication adherence criteria.

METHODS

Pharmacy patients filling a new medication prescription (n = 342) were recruited from 14 Michigan pharmacies to participate in a 4-week treatment satisfaction study. The TSQM v. II was tested for model fit against an established theoretical model (the Decisional Balance Model of Treatment Satisfaction) using hierarchical confirmatory factor analysis (HCFA). Regression and discriminant analytic models were used to examine the criterion-related validity of the measure.

RESULTS

An exploratory factor analysis, used for TSQM v. II item reduction, revealed a strongly dimensional instrument (Effectiveness, Side Effects, and Convenience) and explained 88% of total pooled variance. Results of an HCFA using the final TSQM v. II items suggested a good model fit with the data (P > 0.54). In support of concurrent validity, the TSQM scales explained between 9% and 20% of the variance in dosing adherence and 60% of the variance in the likelihood of future use. Discriminant analysis demonstrated the superior classification power of the hierarchical model of treatment satisfaction over the discrete attribute model when predicting medication discontinuation.

CONCLUSIONS

The TSQM v. II has equivalent measurement characteristics as the TSQM v. I, yet uses four fewer items and more consistent wording. The value of the Decisional Balance Model for estimation of dosing adherence and medication persistence over time is discussed.

摘要

目的

本研究有两个目的:1)使用结构方程模型(SEM)评估药物治疗满意度问卷(TSQM v. II)的结构效度;2)使用药物依从性标准评估其同时效度。

方法

从密歇根州的14家药房招募了填写新药物处方的药房患者(n = 342),参与一项为期4周的治疗满意度研究。使用分层验证性因子分析(HCFA),将TSQM v. II与已建立的理论模型(治疗满意度决策平衡模型)进行模型拟合测试。使用回归和判别分析模型来检验该测量方法与标准相关的效度。

结果

用于减少TSQM v. II项目的探索性因子分析显示,该量表具有很强的维度性(有效性、副作用和便利性),解释了总合并方差的88%。使用最终的TSQM v. II项目进行的HCFA结果表明,该模型与数据拟合良好(P > 0.54)。为支持同时效度,TSQM量表解释了给药依从性方差的9%至20%以及未来使用可能性方差的60%。判别分析表明,在预测药物停药时,治疗满意度分层模型比离散属性模型具有更强的分类能力。

结论

TSQM v. II具有与TSQM v. I同等的测量特性,但项目少了四项,措辞更一致。讨论了决策平衡模型在估计给药依从性和药物持续时间方面的价值。

相似文献

1
Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers.门诊药房消费者中药物治疗满意度问卷(TSQM 第二版)的层次结构效度
Value Health. 2005 Nov-Dec;8 Suppl 1:S9-S24. doi: 10.1111/j.1524-4733.2005.00066.x.
2
Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease.使用全国慢性病小组研究对一种治疗满意度通用测量工具——药物治疗满意度问卷(TSQM)进行验证。
Health Qual Life Outcomes. 2004 Feb 26;2:12. doi: 10.1186/1477-7525-2-12.
3
Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications.高血压药物治疗患者中简化版药物治疗满意度问卷(TSQM-9)的验证
Health Qual Life Outcomes. 2009 Apr 27;7:36. doi: 10.1186/1477-7525-7-36.
4
Satisfaction with methadone as a medication: psychometric properties of the Spanish version of the treatment satisfaction questionnaire for medication.患者对美沙酮作为一种药物的满意度:药物治疗满意度问卷西班牙版本的心理测量学特性。
J Clin Psychopharmacol. 2012 Feb;32(1):69-74. doi: 10.1097/JCP.0b013e3182401e09.
5
Development and validation of the "Treatment Satisfaction with Medicines Questionnaire" (SATMED-Q).《药物治疗满意度问卷》(SATMED-Q)的编制与验证
Value Health. 2008 Sep-Oct;11(5):913-26. doi: 10.1111/j.1524-4733.2008.00323.x. Epub 2008 May 20.
6
Psychometric validation of anti-clot treatment scale and treatment satisfaction questionnaire for medication version II in Japanese patients with atrial fibrillation.抗栓治疗量表和药物版 II 治疗满意度问卷在日本心房颤动患者中的心理计量学验证。
J Med Econ. 2019 Aug;22(8):798-805. doi: 10.1080/13696998.2019.1609003. Epub 2019 May 13.
7
A new measure of patient satisfaction with ocular hypotensive medications: the Treatment Satisfaction Survey for Intraocular Pressure (TSS-IOP).一种衡量患者对降眼压药物满意度的新方法:眼压治疗满意度调查(TSS-IOP)。
Health Qual Life Outcomes. 2003 Nov 15;1:67. doi: 10.1186/1477-7525-1-67.
8
Treatment Satisfaction Questionnaire for Medication (TSQM version 1.4): Ceiling and Floor Effects, Reliability, and Known-Group Validity in Brazilian Outpatients With Hypertension.治疗满意度问卷药物版(TSQM 1.4 版):巴西高血压门诊患者中的天花板和地板效应、信度和已知组有效性。
Value Health Reg Issues. 2020 Dec;23:150-156. doi: 10.1016/j.vhri.2020.07.578. Epub 2020 Nov 4.
9
Satisfaction with medication in coronary disease treatment: psychometrics of the Treatment Satisfaction Questionnaire for Medication.冠心病治疗中对药物治疗的满意度:药物治疗满意度问卷的心理测量学
Rev Lat Am Enfermagem. 2016 Jun 7;24. doi: 10.1590/1518-8345.0745.2705.
10
Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?衡量多发性硬化症的治疗满意度:药物治疗满意度问卷是否适用?
Mult Scler. 2017 Apr;23(4):604-613. doi: 10.1177/1352458516657441. Epub 2016 Jul 11.

引用本文的文献

1
Three-year real-world outcomes of lanadelumab prophylaxis in hereditary angioedema: Complete disease suppression and psychosocial benefits in two East Asian patients.遗传性血管性水肿患者使用lanadelumab预防治疗的三年真实世界疗效:两名东亚患者实现疾病完全抑制并获得心理社会益处
Intractable Rare Dis Res. 2025 Aug 31;14(3):210-215. doi: 10.5582/irdr.2025.01045.
2
CONKO-011/AIO-SUP-0115/ass.: Rivaroxaban Compared to Low Molecular Weight Heparin in Cancer Patients with Acute Venous Thromboembolism.CONKO-011/AIO-SUP-0115研究:利伐沙班与低分子肝素在急性静脉血栓栓塞症癌症患者中的比较。
Oncol Res Treat. 2025 May 26:1-10. doi: 10.1159/000545976.
3
Medication adherence scales in non-communicable diseases: A scoping review of design gaps, constructs and validation processes.
非传染性疾病中的药物依从性量表:对设计差距、结构和验证过程的范围审查
PLoS One. 2025 May 14;20(5):e0321423. doi: 10.1371/journal.pone.0321423. eCollection 2025.
4
Patient Satisfaction and Resource Utilization Following Introduction of Long-Acting Injectable Buprenorphine (LAIB) in Scottish Prisons.长效注射用丁丙诺啡(LAIB)引入苏格兰监狱后的患者满意度和资源利用情况
Subst Abuse Rehabil. 2025 Apr 15;16:83-93. doi: 10.2147/SAR.S510467. eCollection 2025.
5
Lower Drug Survival, Less Satisfaction and More Adverse Events in Females Using Biologics for Psoriasis: Results of the Dutch BioCAPTURE Registry.荷兰生物制剂治疗银屑病患者注册研究(BioCAPTURE)结果显示:女性使用生物制剂治疗银屑病时药物留存率较低、满意度较低且不良事件较多 。
J Psoriasis Psoriatic Arthritis. 2025 Apr 1:24755303251327926. doi: 10.1177/24755303251327926.
6
A study protocol for exploring and implementing a surgical pharmaceutical service model in drug treatment management for patients with osteoporosis fracture in China.一项关于在中国探索并实施针对骨质疏松性骨折患者药物治疗管理的外科药学服务模式的研究方案。
Front Med (Lausanne). 2025 Mar 12;12:1502360. doi: 10.3389/fmed.2025.1502360. eCollection 2025.
7
Changes in Tendon Thickness After Chondrovita FIT Supplementation in Elite Skaters: Findings from a Quasi-Experimental Study.精英滑冰运动员补充Chondrovita FIT后肌腱厚度的变化:一项准实验研究的结果
Int J Environ Res Public Health. 2024 Dec 28;22(1):24. doi: 10.3390/ijerph22010024.
8
A landscape review to identify what matters to patients with thrombotic cardiovascular diseases and patient-reported outcome instruments which can be used to capture the patient experience.一项全景综述,旨在确定对血栓性心血管疾病患者重要的事项以及可用于获取患者体验的患者报告结局工具。
Qual Life Res. 2025 Jan;34(1):101-111. doi: 10.1007/s11136-024-03790-1. Epub 2024 Nov 22.
9
Development and Content Validation of the Patient's Qualitative Assessment of Treatment - Real-World (PQAT-RW): An Instrument to Evaluate Benefits and Disadvantages of Treatments in Real-World Settings.患者治疗定性评估-真实世界(PQAT-RW)的开发与内容验证:一种评估真实世界中治疗利弊的工具
Patient Relat Outcome Meas. 2024 Oct 7;15:255-269. doi: 10.2147/PROM.S468623. eCollection 2024.
10
Application of Alfalfa App in the management of oral anticoagulation in patients with atrial fibrillation: a multicenter randomized controlled trial.苜蓿在心房颤动患者口服抗凝管理中的应用:一项多中心随机对照试验。
BMC Med Inform Decis Mak. 2024 Oct 9;24(1):294. doi: 10.1186/s12911-024-02701-1.